There is great, unmet need in understanding and monitoring non-invasively the immune cell changes within the tumour stromal microenvironment during cancer treatment. However there is as yet no reliable non-invasive method of identifying at very early time points patients who are most likely to benefit from this relatively expensive class of treatments which generally are only associated with a clinical response in 25-30% of patients1. We show here in a mouse model that changes 11 days after implantation in the liquid-to-solid ratio (phase angle y) of the tumour biomechanics are indicative for successful immune cell – stromal cell interactions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords